Zurueck zur Suche

Reporte zur Charge 2ZF9N

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

30Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 6 PA 3 TX 3 CT 3 CA 2 KY 2 NY 1 AZ 1 PR 1 SD 1 KS 1 ID 1

VAERS 2685951

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

schwer
Staat
NY
Alter
13,0
Geschlecht
M
Eingang
25.09.2023
Impfdatum
23.09.2023
Beginn
23.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pallor Syncope

Symptomtext

Patient experienced syncope after receiving Hep A, influenza, MenACWY, Tdap, and varicella vaccines. Briefly unresponsive, pale complexion. Recovered quickly; monitored for almost 1 hour.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2658369

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

schwer
Staat
CA
Alter
11,0
Geschlecht
M
Eingang
19.07.2023
Impfdatum
17.07.2023
Beginn
17.07.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Syncope

Symptomtext

patient waiting 15 minutes to see if no reactions with vaccines, after 5 minutes after administering vaccines, patient fainted in room, ambulance was called per Provider and patient was taken via ambulance to Hospital. Patient followed up in office today 07/19/2023 with our provider.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None Known
Vorherige Impfungen
-

VAERS 2633816

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

schwer
Staat
CA
Alter
20,0
Geschlecht
F
Eingang
18.05.2023
Impfdatum
16.05.2023
Beginn
16.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Hypotension Syncope

Symptomtext

Pt experienced a syncopal episode 10 minutes after vaccine administration. Pt reported dizziness and lightheadedness before syncope and was alert again after 10 seconds w/ low blood pressure. Pt evaluated by MD and felt better after legs being elevated and being given juice and crackers. Pt BP improved and pt was discharged home w/ follow up visit w/ PCP scheduled for later date.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
unknown
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2601971

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

schwer
Staat
PA
Alter
50,0
Geschlecht
F
Eingang
22.03.2023
Impfdatum
22.03.2023
Beginn
22.03.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Seizure

Symptomtext

PT HAS NO HISTORY OF SEIZURE BUT HAD A SEIZURE A FEW MINUTES AFTER RECEIVING BOTH VACCINATIONS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
PT WAS SENT BY FACILITY VIA AMBULANCE TO EMERGENCY ROOM
Aktuelle Erkrankungen
NONE STATED
Vorgeschichte
NEWLY DIAGNOSED WITH LONG COVID AND PERIPHERAL NEUROPATHY
Andere Medikamente
VITAMIN D 50MCG, 1 PO QD VITAMIN B12 1000MCG , 1 PO QD CETIRIZINE 10MG, 1 PO QD MAYBE TRAZODONE 25MG QHS
Allergien
MORPHINE ALLERGY--PT STATED OUT OF BODY FEELING
Vorherige Impfungen
-

VAERS 2497773

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

schwer
Staat
TX
Alter
13,0
Geschlecht
F
Eingang
03.11.2022
Impfdatum
01.11.2022
Beginn
01.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

Pt experienced syncopal event 4 min after immunization received. Slight movement noted of left arm and left leg for 15 seconds while syncopal event lasted. Pt regained consciousness 30 seconds after syncopal event started. Applied cold towel to forehead and cheeks, Pt maintained a pulse during syncopal event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None reported by Parent
Vorgeschichte
None reported by Parent at time of Immunization.
Andere Medikamente
None reported by Parent
Allergien
None reported by Parent
Vorherige Impfungen
-

VAERS 2627348

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

moderat
Staat
MI
Alter
23,0
Geschlecht
F
Eingang
05.05.2023
Impfdatum
02.05.2023
Beginn
04.05.2023
Tage bis Beginn
2,0
Dosis
7+
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chest discomfort Chest pain Painful respiration

Symptomtext

Patient called on 5/5/23 stating she has an aching pain in her chest, especially at the end of an exhale. Described and discomfort and ache in her chest.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
History of Myocarditis and Pericarditis, history of heart surgery
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2663547

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

mild
Staat
PA
Alter
12,0
Geschlecht
M
Eingang
31.07.2023
Impfdatum
31.07.2023
Beginn
31.07.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Pallor

Symptomtext

After all 3 shots were given and bandaids were being applied the patient turned white and got light headed. I grabbed him and laid him down on the table. Dr came in and checked on him. We had patient lay there for awhile then he sat up for awhile on the table. When he felt better he walked to the chair in the room and sat down for the rest of the 20 minutes. Patient was able to walk out on his own with dad.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2590322

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2zf9n

mild
Staat
MI
Alter
13,0
Geschlecht
F
Eingang
02.03.2023
Impfdatum
07.02.2023
Beginn
07.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pruritus Rash

Symptomtext

Client states itching and rash on chest/neck in the waiting room approx. 5 min after receiving vaccines. Pt assessment done. 50 MG of Benadryl was given within a few min of patient reporting symptoms. Patient was assessed for half an hour. After a half hour patient self reported feeling better via translator and left the clinic.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
No reported
Vorgeschichte
None reported
Andere Medikamente
None reported
Allergien
None Reported
Vorherige Impfungen
-

VAERS 2527046

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

mild
Staat
AZ
Alter
54,0
Geschlecht
M
Eingang
08.12.2022
Impfdatum
08.12.2022
Beginn
08.12.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site reaction Urticaria

Symptomtext

WELT BEGAN TO FORM IN PATIENTS ARM RIGHT AS VACCINE WAS ADMINISTERED. PATIEN DECLINED ANY PAIN INWELT OR SURROUNDING AREAS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
HYPERLIPIDEMIA
Andere Medikamente
- GABAPENTIN 100MG 3X DAILY - HYDROCHLOROTHIAZIDE 25MG ONCE A DAY - HYDROXIZINE HCI 10MG 2X A DAY PRN - IBUPROFEN 800MG PRN
Allergien
PENICILLINS
Vorherige Impfungen
-

VAERS 2433746

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

mild
Staat
PR
Alter
11,0
Geschlecht
F
Eingang
08.09.2022
Impfdatum
06.09.2022
Beginn
06.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Nausea

Symptomtext

After being vaccinated, the patient presents dizziness and nausea. She is given the required medical attention and remains under observation until she is stable.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2725999

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2zf9n

gering
Staat
MI
Alter
62,0
Geschlecht
F
Eingang
20.12.2023
Impfdatum
11.12.2023
Beginn
11.12.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

States an expired dose of BOOSTRIX was given to a patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 62-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 2zf9n, expiry date 24-SEP-2023) for prophylaxis. On 11-DEC-2023, the patient received Boostrix. On 11-DEC-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: States an expired dose of BOOSTRIX was given to a patient). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-DEC-2023 The reporter stated that an expired dose of Boostrix was given to a patient, which led to expired vaccine used. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2693016

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
PA
Alter
-
Geschlecht
F
Eingang
09.10.2023
Impfdatum
29.09.2023
Beginn
29.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

expired dose of Boostrix was administered to a patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 67-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 2ZF9N, expiry date 24-SEP-2023) for prophylaxis. On 29-SEP-2023, the patient received Boostrix. On 29-SEP-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: expired dose of Boostrix was administered to a patient). The outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt date: 29-SEP-2023 The reporter called to report that an expired dose of Boostrix was administered to a patient, which led to expired vaccine used. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2692192

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
KY
Alter
-
Geschlecht
F
Eingang
06.10.2023
Impfdatum
27.09.2023
Beginn
27.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

patient received a dose of Boostrix that had already expired; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 2ZF9N, expiry date 24-SEP-2023) for prophylaxis. On 27-SEP-2023, the patient received Boostrix. On 27-SEP-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: patient received a dose of Boostrix that had already expired). The outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt date: 27-SEP-2023 A nurse reported that earlier that day, a patient received a dose of Boostrix that had already expired on 24 September 2023 which led to expired vaccine used. The reporter did not consent to follow-up. This case was linked with case US2023133461 with same reporter.; Sender's Comments: US-GSK-US2023133461:Same reporter 2nd patient

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2691190

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
SD
Alter
12,0
Geschlecht
F
Eingang
05.10.2023
Impfdatum
25.09.2023
Beginn
25.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

patient received a dose of Boostrix that expired the day before she was administered it; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 12-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 2ZF9N, expiry date 24-SEP-2023) for prophylaxis. On 25-SEP-2023, the patient received Boostrix. On 25-SEP-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: patient received a dose of Boostrix that expired the day before she was administered it). The outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 26-Sept-2023 The case was received from the registered nurse. The reporter consented to follow-up. The patient received an expired dose of Boostrix, which led to expired vaccine used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2691184

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
KS
Alter
12,0
Geschlecht
M
Eingang
05.10.2023
Impfdatum
26.09.2023
Beginn
26.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

patient received an expired dose of Boostrix today. Vaccine expired on 24-SEP-2023; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 12-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 2ZF9N, expiry date 24-SEP-2023) for prophylaxis. On 26-SEP-2023, the patient received Boostrix. On 26-SEP-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: patient received an expired dose of Boostrix today. Vaccine expired on 24-SEP-2023). The outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 26-Sept-2023 The case was received from the registered nurse. The reporter consented to follow-up. The patient received an expired dose of Boostrix, which led to expired vaccine used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2690824

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
KY
Alter
-
Geschlecht
F
Eingang
04.10.2023
Impfdatum
27.09.2023
Beginn
27.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

a patient received a dose of Boostrix that had already expired on 24/Sep/2023; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 2ZF9N, expiry date 24-SEP-2023) for prophylaxis. On 27-SEP-2023, the patient received Boostrix. On 27-SEP-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: a patient received a dose of Boostrix that had already expired on 24/Sep/2023). The outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt Date: 27-SEP-2023 A nurse called to inform that earlier that day, a patient received a dose of Boostrix that had already expired on 24th September 2023, which led to expired vaccine used. The reporter did not consent to follow-up. This case had been linked with US2023133458, reported by same reporter.; Sender's Comments: US-GSK-US2023133458:Same reporter 2nd patient

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2690819

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
-
Alter
-
Geschlecht
M
Eingang
04.10.2023
Impfdatum
25.09.2023
Beginn
25.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Administration of an expired Boostrix dose to a patient.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 61-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 2ZF9N, expiry date 24-SEP-2023) for prophylaxis. On 25-SEP-2023, the patient received Boostrix. On 25-SEP-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: Administration of an expired Boostrix dose to a patient.). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 25-SEP-2023 The reporter reported that the patient received Boostrix vaccine which was already expired, which led to expired vaccine used. The reporter asked if the patient had to be re vaccinated. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2674297

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
TX
Alter
7,0
Geschlecht
M
Eingang
21.08.2023
Impfdatum
19.08.2023
Beginn
19.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Unevaluable event

Symptomtext

On Saturday, 8/19/2023, the vaccinating LVN did not remember which vaccine she administered in the client's left deltoid. The client did not appear to exhibit signs or symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2658565

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
ID
Alter
12,0
Geschlecht
M
Eingang
19.07.2023
Impfdatum
19.07.2023
Beginn
19.07.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Wrong product administered

Symptomtext

Pt was due for Meningococcal-MCV4. I made the mistake and gave pt VAXNEUVANCE instead. I notified vaccine supervisor, clinic manager and Clinic Dr. I am trying to contact mom and let her know of the mistake and to bring pt back to administer the correct vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
no
Vorgeschichte
bicuspid aortic valve
Andere Medikamente
no
Allergien
NKA
Vorherige Impfungen
-

VAERS 2610819

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (OTHER) · Charge 2ZF9N

gering
Staat
NV
Alter
4,0
Geschlecht
F
Eingang
06.04.2023
Impfdatum
05.04.2023
Beginn
05.04.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Unevaluable event

Symptomtext

No symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Tdap vaccine
Allergien
None
Vorherige Impfungen
-

VAERS 2590860

SANOFI PASTEUR · TDAP (ADACEL) · Charge 2ZF9N

gering
Staat
MI
Alter
17,0
Geschlecht
M
Eingang
03.03.2023
Impfdatum
02.03.2023
Beginn
02.03.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

Inadvertently gave MMRV which is not for the age group of 17 and older, also in giving the MMRV, this nurse also gave a dose of Varicella to the client. After giving the doses Supervisor notified, as well as Dr. notified. Contact made to current residence of patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
N/A
Allergien
None identified
Vorherige Impfungen
-

VAERS 2568721

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
UT
Alter
14,0
Geschlecht
M
Eingang
26.01.2023
Impfdatum
24.01.2023
Beginn
24.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

should have given a Varicella shot instead of a Proquad

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2550061

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
MI
Alter
13,0
Geschlecht
F
Eingang
04.01.2023
Impfdatum
04.01.2023
Beginn
04.01.2023
Tage bis Beginn
0,0
Dosis
6
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

RN intended to administer Meningococcal Conjugate; Administered Meningococcal B in error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Unknown
Allergien
None
Vorherige Impfungen
-

VAERS 2548863

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
NJ
Alter
11,0
Geschlecht
M
Eingang
03.01.2023
Impfdatum
03.01.2023
Beginn
03.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered

Symptomtext

This child was given Pfizer Bivalent 12 and up dose (0.3ml) instead of Pfizer Bivalent 5-11 years (0.2ml)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
Zofran
Vorherige Impfungen
-

VAERS 2510752

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
VT
Alter
22,0
Geschlecht
F
Eingang
17.11.2022
Impfdatum
17.11.2022
Beginn
17.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

Pt given Covid 19 Bivalent vaccine .Pt had previously received one on 10/13/22

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2497632

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
MI
Alter
13,0
Geschlecht
M
Eingang
03.11.2022
Impfdatum
01.11.2022
Beginn
01.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administration error Wrong product administered

Symptomtext

The patient was gave a Meningococcal Group B , instead of Meningococcal Conjugate (MCV4).. There has been no treatment, the parent has been notified along wit a vaccine administration error report has been submitted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administration error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2469956

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
TX
Alter
15,0
Geschlecht
M
Eingang
05.10.2022
Impfdatum
05.10.2022
Beginn
05.10.2022
Tage bis Beginn
0,0
Dosis
6
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Circumstance or information capable of leading to medication error Extra dose administered No adverse event Product administered to patient of inappropriate age

Symptomtext

Student was administered Tdap and MCV4 based on Immunization record provided at tie of immunization which did not included Tdap and MCV4 doses. Student tolerated immunization swell, no Sx reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circumstance or information capable of leading to medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2456151

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
CT
Alter
11,0
Geschlecht
M
Eingang
23.09.2022
Impfdatum
22.09.2022
Beginn
22.09.2022
Tage bis Beginn
0,0
Dosis
5
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product preparation issue

Symptomtext

Covid vaccine found to have not been diluted prior to administration.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product preparation issue
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
None Known
Vorgeschichte
ADHD
Andere Medikamente
Children's Chewable Multivitamin
Allergien
None Known
Vorherige Impfungen
-

VAERS 2441011

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2zf9n

gering
Staat
CT
Alter
9,0
Geschlecht
F
Eingang
12.09.2022
Impfdatum
12.09.2022
Beginn
12.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect product formulation administered

Symptomtext

0.2ml of undiluted covid19 pfizer 5-11 administered, no symptoms/signs to date.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Undiluted Covid19 pfizer 5-11 vaccine administration. 0.2ml
Allergien
none
Vorherige Impfungen
-

VAERS 2441010

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 2ZF9N

gering
Staat
CT
Alter
11,0
Geschlecht
F
Eingang
12.09.2022
Impfdatum
12.09.2022
Beginn
12.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product preparation error

Symptomtext

Patient received 0.2 ml of undiluted Pfizer Covid vaccine 5-11yrs. No symptoms reported to date

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none
Vorgeschichte
asthma
Andere Medikamente
Proventil HFA inh
Allergien
nkda
Vorherige Impfungen
-